Coherus Confident On Avastin This Year With Humira Goal Achieved

Filing Of Adalimumab Was Slated For Q4 2020

Having delivered on a goal to file its Humira biosimilar with the FDA by the end of last year, Coherus BioSciences is now focused on getting its in-licensed bevacizumab product filing over the line, as it scans the market for further growth opportunities.

Light bulb
Coherus is aiming to file its partnered bevacizumab in the back half of this year. • Source: Shutterstock

Coherus BioSciences is on course to file a biologics license application in the US for partner Innovent Biologics’ Avastin (bevacizumab) biosimilar in the second half of 2021, management has revealed, after confirming that Coherus’ wholly-owned Humira (adalimumab) biosimilar application has now been filed with the US Food and Drug Administration.

“We project the BLA filing for the second half of 2021. The Phase III has been successfully completed by our...

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Biosimilars

More from Products

  • For Generics, A Victory Lap – And A Warning – On Drug Shortages

    Avoiding disaster at the beginning of the pandemic and offering a pro-active supply chain blueprint should position the generics industry well for an onshoring debate in Congress, but a look back at March 2020 is a reminder that even small policy shifts can have a big impact.

  • GB-Free-Company-The Secret to Walking More: It’s Not Counting Steps

    We’ve all been told that walking 10,000 steps a day is the magic number for better health. But what if the real secret to walking more isn’t about counting steps at all? In this article, we explore how focusing on motivation, environment, and mindset can help you build a walking habit that lasts.

  • Biocon And Teva Sign Up To Biosimilars Forum

    Teva and Biocon Biologics have become the latest firms to sign up to the Biosimilars Forum industry association in the US.